
2-Year Study: Testosterone Undecanoate Improves Lipid Profiles in American Males
Reading Time: 3 minutes Introduction Testosterone replacement therapy (TRT) has become increasingly prevalent among American males seeking to mitigate the effects of hypogonadism, a condition characterized by abnormally low levels of testosterone. Among the various formulations available, testosterone undecanoate has garnered attention for its long-acting nature and potential metabolic benefits. This article delves into a 2-year prospective study examining the effects of testosterone undecanoate on lipid profiles in American males, offering valuable insights into its cardiovascular implications. Study Design and Methodology The study involved a cohort of 200 American males aged between 40 and 65 years, diagnosed with hypogonadism and exhibiting baseline total testosterone...